Scientific Communication for Reimbursement Success
Peer-Reviewed Publications & Value Dossiers
We translate technical analyses into persuasive, publication-ready narratives and HTA-aligned dossiers—manuscripts, posters, HEOR reports, and payer submissions.
Expert Medical Writing Capabilities
We combine scientific rigor with strategic communication, ensuring your publications and payer documents connect with audiences and withstand scientific scrutiny.
Journal Submissions & Publication Strategy
End-to-end support from target journal selection through peer review and acceptance.
Peer-Reviewed Manuscripts
Original research articles, systematic reviews, and meta-analyses.
Health Economics Model Documentation
Technical reports for cost-effectiveness and budget impact models.
Study Protocols & Reports
RWE study protocols, statistical analysis plans, and final study reports.
Payer Presentation Materials
Value dossiers and reimbursement submissions tailored to HTA requirements.
Conference Abstracts & Posters
Structured abstracts and visually compelling poster designs for key congresses.
White Papers
In-depth evidence summaries and position papers for stakeholder engagement.
Quality Standards & Expertise
Our medical writing follows the highest academic & industry standards
Compliance
Following international journal standards & industry guidelines
Excellence
Writing from clinical experts
Experience
Fast and science-first quality
Selected Publications
Demonstrating our expertise through peer-reviewed publications and evidence-based research across multiple therapeutic areas and methodology domains
Economic evaluation of a bivalent respiratory syncytial virus prefusion F vaccine for older adults in Sweden: cost-effectiveness and budget impact
Szilcz M, Naghipour P, Fridh A-C, Palmborg A, Toghanian S
Journal of Medical Economics 28(1):1955-1967
2025
Prescribing trends and time series analysis of blood pressure-lowering drugs among patients with dementia: a multinational database study
Cheung ECL, Wang Y, Ellett LK, Adesuyan M, Szilcz M, Shah S, Pratt N, Brauer R, Jani YH, Smith RD, Luo H, Yuen JK, Hagg S, Chui CSL
eClinicalMedicine 90:103595
2025
EE477 Forecasting Uptake of Novel Drugs Used for Atopic Dermatitis in Sweden Based on Historic RWE
Szilcz M, Nilsson FOL, Naghipour P
Value in Health 28(12):s199
2025
EPH180 Pharosight: A Shiny-Based Interactive Platform With LLM-Enhanced Analyses and Predictive Modeling for Real-World Prescription Data
Szilcz M, Naghipour P
Value in Health 28(12):s299
2025
MSR106 extRpolateS: A Shiny-Based Interactive Platform for Time-to-Event Data Modeling in Health Technology Assessments
Szilcz M, Naghipour P
Value in Health 28(12):s514-s515
2025
Impact of dementia on risks of COVID-19 infection and outcomes among older adults in Sweden
Hoang MT, Wastesson JW, Szilcz M, Maura G, Blotiere P-O, Johnell K
BMC Geriatrics 25(1):843
2025
Changes in use and utilisation patterns of drugs with reported shortages between 2010 and 2024 in Europe and North America: a network cohort study
Pineda-Moncusí M, Rekkas A, Martínez Pérez Á, Leis A, Lopez Gomez C, Fey E, et al.
Lancet Public Health 10(10):e835-e847
2025
Discontinuing Chronic Medications Suggested for Deprescribing in Routine Clinical Practice: Nationwide Evidence From Routinely Collected Data in Swedish Older Adults
Kamgang K-HS, Lundby C, Szilcz M, Johnell K, Wastesson JW
Basic & Clinical Pharmacology & Toxicology 137(3):e70093
2025
Late Deprescribing of Angiotensin-Converting-Enzyme Inhibitors and Renin-Angiotensin Blockers in Patients with Advanced Cancer Receiving Palliative Care
Bjorkhem-Bergman L, Hedman C, Szilcz M, Frisk G
Palliative Medicine Reports 6(1):403-407
2025
CDK 4/6 inhibitor switching and associated dosing patterns in Swedish HR+/HER2-MBC patients
Nyqvist D, Valachis A, Lindman H, Szilcz M, Jakobsson M
Clinical Cancer Research 31(12):p4-07-26
2025
Antihypertensive drug classes and risk of incident dementia: a multinational population-based cohort study
Cheung ECL, Adesuyan M, Szilcz M, Ellett LMK, Shah S, Jani YH, Hagg S, Pratt N, Lau KK, Luo H, Wan EYF, Chan EWY, Wong ICK, Yuen JK, Yiu K-H, Howard R, Brauer R, Chui CSL
Age and Ageing 54(5):afaf121
2025
Antibiotic Use and Risk of Microscopic Colitis in Older Adults: A Nationwide Self-Controlled Case Series Study
Szilcz M, Wastesson JW, Bergman D, Johnell K, Ludvigsson JF
Alimentary Pharmacology & Therapeutics 61(9):1500-1507
2025
Real-World Treatment Patterns and Drug-Related Costs of Ulcerative Colitis: A Retrospective Cohort Study in Sweden
Szilcz M, González EM, Naghipour P, Toghanian S
Value in Health 27(12):s82
2024
Treatment with Antithrombotics in the Last Year of Life—Incidence of Bleeding and Side Effects After Deprescribing
Frisk G, Szilcz M, Hedman C, Bjorkhem-Bergman L
Journal of Palliative Medicine 27(10):1310-1317
2024
Comparative effectiveness of glucagon-like peptide-1 agonists, dipeptidyl peptidase-4 inhibitors, and sulfonylureas on the risk of dementia in older individuals with type 2 diabetes in Sweden: an emulated trial study
Tang B, Sjolander A, Wastesson JW, Maura G, Blotiere P-O, Szilcz M, Mak JKL, Qin C, Alvarsson M, Religa D, Johnell K, Hagg S
eClinicalMedicine 73:102689
2024
Cholinesterase inhibitors and non-steroidal anti-inflammatory drugs and the risk of peptic ulcers: A self-controlled study
Szilcz M, Wastesson JW, Calderon-Larranaga A, Prieto-Alhambra D, Blotiere P-O, Maura G, Johnell K
Journal of the American Geriatrics Society 72(2):456-466
2024
Risk of COVID-19 infection, hospitalization, and mortality in older adults with versus without dementia during the first wave of COVID-19 pandemic: A Swedish nationwide study
Hoang MT, Wastesson J, Szilcz M, Maura G, Blotière P, Johnell K
Alzheimer's & Dementia 19(S24)
2023
Endocrine treatment near the end of life among older women with metastatic breast cancer: a nationwide cohort study
Szilcz M, Wastesson JW, Calderon-Larranaga A, Morin L, Lindman H, Johnell K
Frontiers in Oncology 13:1223563
2023
Potential overtreatment in end-of-life care in adults 65 years or older dying from cancer: applying quality indicators on nationwide registries
Szilcz M, Wastesson JW, Morin L, Calderon-Larranaga A, Lambe M, Johnell K
Acta Oncologica 61(12):1437-1445
2022
Overall survival of patients with metastatic breast cancer in Sweden: a nationwide study
Valachis A, Carlqvist P, Ma Y, Szilcz M, Freilich J, Vertuani S, Holm B, Lindman H
British Journal of Cancer 127(4):720-725
2022
Cost-effectiveness analysis of superabsorbent wound dressings in patients with moderate-to-highly exuding leg ulcers in Germany
Velickovic VM, Szilcz M, Milosevic Z, Godfrey T, Siebert U
International Wound Journal 19(2):447-459
2022
Use of classifiers to optimise the identification and characterisation of metastatic breast cancer in a nationwide administrative registry
Valachis A, Carlqvist P, Szilcz M, Freilich J, Vertuani S, Holm B, Lindman H
Acta Oncologica 60(12):1604-1610
2021
Unplanned hospitalisations in older people: illness trajectories in the last year of life
Szilcz M, Wastesson JW, Johnell K, Morin L
BMJ Supportive & Palliative Care 14(E1):E961
2021
Income inequalities in leisure time physical inactivity in northern Sweden: A decomposition analysis
Szilcz M, Mosquera PA, San Sebastian M, Gustafsson PE
Scandinavian Journal of Public Health 48(4):442-451
2020
Time trends in absolute and relative socioeconomic inequalities in leisure time physical inactivity in northern Sweden
Szilcz M, Mosquera PA, Sebastian MS, Gustafsson PE
Scandinavian Journal of Public Health 46(1):112-123
2018
Economic evaluation of a bivalent respiratory syncytial virus prefusion F vaccine for older adults in Sweden: cost-effectiveness and budget impact
Szilcz M, Naghipour P, Fridh A-C, Palmborg A, Toghanian S
Journal of Medical Economics 28(1):1955-1967
2025
Prescribing trends and time series analysis of blood pressure-lowering drugs among patients with dementia: a multinational database study
Cheung ECL, Wang Y, Ellett LK, Adesuyan M, Szilcz M, Shah S, Pratt N, Brauer R, Jani YH, Smith RD, Luo H, Yuen JK, Hagg S, Chui CSL
eClinicalMedicine 90:103595
2025
EE477 Forecasting Uptake of Novel Drugs Used for Atopic Dermatitis in Sweden Based on Historic RWE
Szilcz M, Nilsson FOL, Naghipour P
Value in Health 28(12):s199
2025
EPH180 Pharosight: A Shiny-Based Interactive Platform With LLM-Enhanced Analyses and Predictive Modeling for Real-World Prescription Data
Szilcz M, Naghipour P
Value in Health 28(12):s299
2025
MSR106 extRpolateS: A Shiny-Based Interactive Platform for Time-to-Event Data Modeling in Health Technology Assessments
Szilcz M, Naghipour P
Value in Health 28(12):s514-s515
2025
Impact of dementia on risks of COVID-19 infection and outcomes among older adults in Sweden
Hoang MT, Wastesson JW, Szilcz M, Maura G, Blotiere P-O, Johnell K
BMC Geriatrics 25(1):843
2025
Changes in use and utilisation patterns of drugs with reported shortages between 2010 and 2024 in Europe and North America: a network cohort study
Pineda-Moncusí M, Rekkas A, Martínez Pérez Á, Leis A, Lopez Gomez C, Fey E, et al.
Lancet Public Health 10(10):e835-e847
2025
Discontinuing Chronic Medications Suggested for Deprescribing in Routine Clinical Practice: Nationwide Evidence From Routinely Collected Data in Swedish Older Adults
Kamgang K-HS, Lundby C, Szilcz M, Johnell K, Wastesson JW
Basic & Clinical Pharmacology & Toxicology 137(3):e70093
2025
Late Deprescribing of Angiotensin-Converting-Enzyme Inhibitors and Renin-Angiotensin Blockers in Patients with Advanced Cancer Receiving Palliative Care
Bjorkhem-Bergman L, Hedman C, Szilcz M, Frisk G
Palliative Medicine Reports 6(1):403-407
2025
CDK 4/6 inhibitor switching and associated dosing patterns in Swedish HR+/HER2-MBC patients
Nyqvist D, Valachis A, Lindman H, Szilcz M, Jakobsson M
Clinical Cancer Research 31(12):p4-07-26
2025
Antihypertensive drug classes and risk of incident dementia: a multinational population-based cohort study
Cheung ECL, Adesuyan M, Szilcz M, Ellett LMK, Shah S, Jani YH, Hagg S, Pratt N, Lau KK, Luo H, Wan EYF, Chan EWY, Wong ICK, Yuen JK, Yiu K-H, Howard R, Brauer R, Chui CSL
Age and Ageing 54(5):afaf121
2025
Antibiotic Use and Risk of Microscopic Colitis in Older Adults: A Nationwide Self-Controlled Case Series Study
Szilcz M, Wastesson JW, Bergman D, Johnell K, Ludvigsson JF
Alimentary Pharmacology & Therapeutics 61(9):1500-1507
2025
Real-World Treatment Patterns and Drug-Related Costs of Ulcerative Colitis: A Retrospective Cohort Study in Sweden
Szilcz M, González EM, Naghipour P, Toghanian S
Value in Health 27(12):s82
2024
Treatment with Antithrombotics in the Last Year of Life—Incidence of Bleeding and Side Effects After Deprescribing
Frisk G, Szilcz M, Hedman C, Bjorkhem-Bergman L
Journal of Palliative Medicine 27(10):1310-1317
2024
Comparative effectiveness of glucagon-like peptide-1 agonists, dipeptidyl peptidase-4 inhibitors, and sulfonylureas on the risk of dementia in older individuals with type 2 diabetes in Sweden: an emulated trial study
Tang B, Sjolander A, Wastesson JW, Maura G, Blotiere P-O, Szilcz M, Mak JKL, Qin C, Alvarsson M, Religa D, Johnell K, Hagg S
eClinicalMedicine 73:102689
2024
Cholinesterase inhibitors and non-steroidal anti-inflammatory drugs and the risk of peptic ulcers: A self-controlled study
Szilcz M, Wastesson JW, Calderon-Larranaga A, Prieto-Alhambra D, Blotiere P-O, Maura G, Johnell K
Journal of the American Geriatrics Society 72(2):456-466
2024
Risk of COVID-19 infection, hospitalization, and mortality in older adults with versus without dementia during the first wave of COVID-19 pandemic: A Swedish nationwide study
Hoang MT, Wastesson J, Szilcz M, Maura G, Blotière P, Johnell K
Alzheimer's & Dementia 19(S24)
2023
Endocrine treatment near the end of life among older women with metastatic breast cancer: a nationwide cohort study
Szilcz M, Wastesson JW, Calderon-Larranaga A, Morin L, Lindman H, Johnell K
Frontiers in Oncology 13:1223563
2023
Potential overtreatment in end-of-life care in adults 65 years or older dying from cancer: applying quality indicators on nationwide registries
Szilcz M, Wastesson JW, Morin L, Calderon-Larranaga A, Lambe M, Johnell K
Acta Oncologica 61(12):1437-1445
2022
Overall survival of patients with metastatic breast cancer in Sweden: a nationwide study
Valachis A, Carlqvist P, Ma Y, Szilcz M, Freilich J, Vertuani S, Holm B, Lindman H
British Journal of Cancer 127(4):720-725
2022
Cost-effectiveness analysis of superabsorbent wound dressings in patients with moderate-to-highly exuding leg ulcers in Germany
Velickovic VM, Szilcz M, Milosevic Z, Godfrey T, Siebert U
International Wound Journal 19(2):447-459
2022
Use of classifiers to optimise the identification and characterisation of metastatic breast cancer in a nationwide administrative registry
Valachis A, Carlqvist P, Szilcz M, Freilich J, Vertuani S, Holm B, Lindman H
Acta Oncologica 60(12):1604-1610
2021
Unplanned hospitalisations in older people: illness trajectories in the last year of life
Szilcz M, Wastesson JW, Johnell K, Morin L
BMJ Supportive & Palliative Care 14(E1):E961
2021
Income inequalities in leisure time physical inactivity in northern Sweden: A decomposition analysis
Szilcz M, Mosquera PA, San Sebastian M, Gustafsson PE
Scandinavian Journal of Public Health 48(4):442-451
2020
Time trends in absolute and relative socioeconomic inequalities in leisure time physical inactivity in northern Sweden
Szilcz M, Mosquera PA, Sebastian MS, Gustafsson PE
Scandinavian Journal of Public Health 46(1):112-123
2018